Exagen (NASDAQ:XGN) just reported results for the first quarter of 2024.
- Exagen reported earnings per share of -19 cents. This was above the analyst estimate for EPS of -36 cents.
- The company reported revenue of $14.42 million.
- This was 10.12% better than the analyst estimate for revenue of $13.09 million.